EFFICACY OF ANTI- INFLAMMATORY SIgAS AFTER TOPICAL TREATMENT IN INFLAMMATORY BOWEL DISEASE DISCLOSURE R. Arends 1, , R. Ubink 1 , M. van der Lee 1 , G. de Roo 2 , L. Dickey 3 , G. Rouwendal 4 , G. Ariaans 4 , W. Dokter 1 1 Preclinical Department, 2 Bio DSP, 3 LEX Platform 4 New Molecular Entities, Synthon Biopharmaceuticals BV, Nijmegen, The Netherlands B. Weigmann, M. Neurath Department of Gastroenterology, Pneumology and Endocrinology of the Medizinische Klinik 1, Erlangen, Germany B. Corthésy Centre Hospitalier Universitaire Vaudois, R & D Laboratory of the Division of Immunology and Allergy, Lausanne, Switzerland
9
Embed
EFFICACY OF ANTI- INFLAMMATORY SIgAS AFTER TOPICAL TREATMENT IN INFLAMMATORY BOWEL DISEASE DISCLOSURE R. Arends 1,, R. Ubink 1, M. van der Lee 1, G. de.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
EFFICACY OF ANTI-INFLAMMATORY SIgAS AFTER TOPICAL TREATMENT IN INFLAMMATORY BOWEL DISEASE
DISCLOSURER. Arends1,, R. Ubink1, M. van der Lee1, G. de Roo2, L. Dickey3, G. Rouwendal4, G. Ariaans4, W. Dokter1
Sc-20656 (human secretory chain) in red, DAPI (Nuclei) in blue
LEFT ULEX-1 (Lectin) in green RIGHT EpCAM (Epithelial cell adhesion molecule) in green
Synthon
BIODISTRIBUTION (QWBA) SIgA IV AND PO
SIgA rapidly cleared from circulation after IV administration t1/2 ~2hVery low systemic exposure after oral administration 6
Intravenous
Oral
Caecu
m c
ontents
Large
inte
stin
e co
ntents
Smal
l inte
stin
e co
ntents
Stom
ach c
ontents
Urinar
y bla
dder: C
ontents
0
20
40
60
80
100
120
140
160
180
200
200250300350400
ug
eq
uiv
ale
nts
/ g
1 hour2 hours
4 hours
8 hours24 hours48 hours72 hours
Bile (g
all b
ladder
)
Kidney
(whole
)
Liver
Lung
Lymph
Spleen
(whole
)
Urinar
y bla
dder c
ontents
0
20
40
60
80
100
120
140
160
180
200
200250300350400
1 hour2 hours4 hours
8 hours24 hours48 hours72 hours
ug
eq
uiv
ale
nts
/ g
Synthon
SIgA IN TNBS-INDUCED IBD MODEL IN MICE
7
SIgA inhibits TNBS-induced IBD after Oral and Rectal administration
Synthon 8
SUMMARY AND CONCLUSION
• We have successfully generated a monoclonal anti-TNFα secretory IgA antibody in duckweed.
• Anti-TNFα SIgA is a promising molecule for topical treatment of IBD, combining elimination of adverse effects associated with systemic exposure with the convenience of topical treatment.